TY - JOUR
T1 - Landmark Series
T2 - Importance of Pancreatic Resection Margins
AU - Shah, Mihir M.
AU - Datta, Jashodeep
AU - Merchant, Nipun B.
AU - Kooby, David A.
N1 - Publisher Copyright:
© 2021, Society of Surgical Oncology.
PY - 2022/3
Y1 - 2022/3
N2 - An important goal of cancer surgery is to achieve negative surgical margins and remove all disease completely. For pancreatic neoplasms, microscopic margins may remain positive despite gross removal of the palpable mass, and surgeons must then consider extending resection, even to the point of completion pancreatectomy, an option that renders the patient with significant adverse effects related to exocrine and endocrine insufficiency. Counterintuitively, extending resection to ensure clear margins may not improve patient outcome. Furthermore, the goal of improving survival by extending the resection may not be achieved, as an initial positive margin may indicate more aggressive underlying tumor biology. There is a growing body of literature on this topic, and this landmark series review will examine the key publications that guide our management for resection of pancreatic ductal adenocarcinoma, intraductal papillary mucinous neoplasms, and pancreatic neuroendocrine tumors.
AB - An important goal of cancer surgery is to achieve negative surgical margins and remove all disease completely. For pancreatic neoplasms, microscopic margins may remain positive despite gross removal of the palpable mass, and surgeons must then consider extending resection, even to the point of completion pancreatectomy, an option that renders the patient with significant adverse effects related to exocrine and endocrine insufficiency. Counterintuitively, extending resection to ensure clear margins may not improve patient outcome. Furthermore, the goal of improving survival by extending the resection may not be achieved, as an initial positive margin may indicate more aggressive underlying tumor biology. There is a growing body of literature on this topic, and this landmark series review will examine the key publications that guide our management for resection of pancreatic ductal adenocarcinoma, intraductal papillary mucinous neoplasms, and pancreatic neuroendocrine tumors.
UR - http://www.scopus.com/inward/record.url?scp=85122353213&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122353213&partnerID=8YFLogxK
U2 - 10.1245/s10434-021-11168-7
DO - 10.1245/s10434-021-11168-7
M3 - Article
C2 - 34985731
AN - SCOPUS:85122353213
VL - 29
SP - 1542
EP - 1550
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
SN - 1068-9265
IS - 3
ER -